Other
CN
EU
USA
Description: HA130 is a novel, potent and selective inhibitor of autotaxin (ATX) with an IC50 of 28 nM. HA130 inhibits the enzymatic activity of ATX, and slows T cell migration across lymph node HEVs in vivo. Ex vivo, HA130 blunts the TEM-promoting activity of ATX, paralleling its in vivo effects. Autotaxin (ATX) is an ectoenzyme that catalyzes the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA), a bioactive lipid and a close relative of sphingosine 1-phosphate.
References: J Immunol. 2013 Mar 1;190(5):2036-48; J Immunol. 2012 Oct 15;189(8):3914-24.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Purity ≥98%
COA
MSDS
Binding of ATX to T cells. J Immunol. 2012 Oct 15;189(8):3914-24.
ATX induces motility of na. J Immunol. 2012 Oct 15;189(8):3914-24.